2010 annual financial data

Supernus Pharmaceuticals 2010 Net margin

Direct answer

Net margin was -36,285.85%.

Operating income was -40,123,000 USD and net income was -38,463,000 USD.
Operating cash flow was -32,544,000 USD.

Get free Supernus Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
106,000 USD
Operating income
-40,123,000 USD
Net income
-38,463,000 USD
Operating cash flow
-32,544,000 USD